Cargando…

Role of Atrial Fibrillation Threshold Evaluation on Guiding Treatment

Atrial fibrillation could be induced reproducibly by 50Hz rapid stimulation which was given through systolic and early diastolic phase of atrial excitation. Duration of atrial fibrillation induced in this way was roughly dependent on the current amplitude of the stimulation. The minimum current that...

Descripción completa

Detalles Bibliográficos
Autor principal: Shirayama, Takeshi
Formato: Texto
Lenguaje:English
Publicado: Indian Pacing and Electrophysiology Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1502055/
https://www.ncbi.nlm.nih.gov/pubmed/16943922
_version_ 1782128417070645248
author Shirayama, Takeshi
author_facet Shirayama, Takeshi
author_sort Shirayama, Takeshi
collection PubMed
description Atrial fibrillation could be induced reproducibly by 50Hz rapid stimulation which was given through systolic and early diastolic phase of atrial excitation. Duration of atrial fibrillation induced in this way was roughly dependent on the current amplitude of the stimulation. The minimum current that could induce long-lasting atrial fibrillation (30sec in the clinical setting, 2sec in the rabbit or rat model) was defined as atrial fibrillation threshold (AFT). AFT was larger in patients who had history of atrial fibrillation than those who did not. Anti-arrhythmic drugs raised AFT by various degrees both in experimental and clinical cases. Long-term efficacy of a drug could be predicted in a patient, measuring how much the drug increased AFT (cut-off point = 5mA increase). AFT is a useful marker to evaluate atrial vulnerability and to guide pharmacological treatment of atrial fibrillation.
format Text
id pubmed-1502055
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Indian Pacing and Electrophysiology Group
record_format MEDLINE/PubMed
spelling pubmed-15020552006-08-29 Role of Atrial Fibrillation Threshold Evaluation on Guiding Treatment Shirayama, Takeshi Indian Pacing Electrophysiol J Review Article Atrial fibrillation could be induced reproducibly by 50Hz rapid stimulation which was given through systolic and early diastolic phase of atrial excitation. Duration of atrial fibrillation induced in this way was roughly dependent on the current amplitude of the stimulation. The minimum current that could induce long-lasting atrial fibrillation (30sec in the clinical setting, 2sec in the rabbit or rat model) was defined as atrial fibrillation threshold (AFT). AFT was larger in patients who had history of atrial fibrillation than those who did not. Anti-arrhythmic drugs raised AFT by various degrees both in experimental and clinical cases. Long-term efficacy of a drug could be predicted in a patient, measuring how much the drug increased AFT (cut-off point = 5mA increase). AFT is a useful marker to evaluate atrial vulnerability and to guide pharmacological treatment of atrial fibrillation. Indian Pacing and Electrophysiology Group 2003-10-01 /pmc/articles/PMC1502055/ /pubmed/16943922 Text en Copyright: © 2003 Shirayama et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Shirayama, Takeshi
Role of Atrial Fibrillation Threshold Evaluation on Guiding Treatment
title Role of Atrial Fibrillation Threshold Evaluation on Guiding Treatment
title_full Role of Atrial Fibrillation Threshold Evaluation on Guiding Treatment
title_fullStr Role of Atrial Fibrillation Threshold Evaluation on Guiding Treatment
title_full_unstemmed Role of Atrial Fibrillation Threshold Evaluation on Guiding Treatment
title_short Role of Atrial Fibrillation Threshold Evaluation on Guiding Treatment
title_sort role of atrial fibrillation threshold evaluation on guiding treatment
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1502055/
https://www.ncbi.nlm.nih.gov/pubmed/16943922
work_keys_str_mv AT shirayamatakeshi roleofatrialfibrillationthresholdevaluationonguidingtreatment